June 21, 2011 8:00am EDT
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE Amex: OPK) today announced that the Company
repurchased approximately 2.4 million shares of its common stock for
approximately $7.8 million, including commissions, from an early
investor in Acuity Pharmaceuticals, the Company's predecessor. The
repurchase was funded with cash on hand.
About OPKO Health, Inc.
We are a multi-national biopharmaceutical and diagnostics company that
seeks to establish industry-leading positions in large and rapidly
growing medical markets by leveraging our discovery, development and
commercialization expertise and our novel and proprietary technologies.
Our current focus is on conditions with major unmet medical needs
including neurological disorders, infectious diseases, oncology and
ophthalmologic diseases.
Source: OPKO Health, Inc.
Released June 21, 2011
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page